Skip to search formSkip to main contentSkip to account menu

doxacurium

Known as: doxacurium [Chemical/Ingredient] 
National Institutes of Health

Related topics

Related topics

5 relations

Narrower (2)

BW A938Udoxacurium chloride
Drug Allergy

Broader (2)

IsoquinolinesNeuromuscular Nondepolarizing Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Dose response, recovery, and cost of doxacurium as a continuous infusion in neurosurgical intensive care unit patients.
OBJECTIVES To determine the optimal dosing of doxacurium as a continuous infusion in neurosurgical patients with traumatic brain… 
Highly Cited
1996
Highly Cited
1996
Upper Airway Closure: A Primary Source of Difficult Ventilation with Sufentanil Induction of Anesthesia
Large-dose opioid induction of anesthesia can lead to difficult ventilation via a mask. Poor ventilatory compliance (VC) may be… 
Highly Cited
1996
Highly Cited
1996
The effects of neuromuscular paralysis on systemic and splanchnic oxygen utilization in mechanically ventilated patients.
OBJECTIVE To evaluate the effect of neuromuscular paralysis on systemic and splanchnic oxygen utilization in patients in… 
Review
1995
Review
1995
New neuromuscular blocking drugs.
The new nondepolarizing neuromuscular blocking drugs have specific advantages over succinylcholine. Rocuronium has an onset of… 
Review
1995
Review
1995
Double-blind, randomized, multicenter study of doxacurium vs. pancuronium in intensive care unit patients who require neuromuscular-blocking agents.
OBJECTIVE To compare the neuromuscular-blocking and hemodynamic effects of doxacurium vs. pancuronium administered by… 
1993
1993
Hemodynamic and pharmacodynamic comparison of doxacurium and pipecuronium with pancuronium during induction of cardiac anesthesia: does the benefit justify the cost?
We compared the pharmacodynamic effects and hospital costs of three long-acting neuromuscular blocking drugs in a prospective… 
1993
1993
Influence of aging on the pharmacokinetics and pharmacodynamics of doxacurium
Doxacurium (30 µg/kg) pharmacokinetics and pharmacodynamics were evaluated in nine elderly (age range, 70 to 83 years) and nine… 
Highly Cited
1991
Highly Cited
1991
Pharmacokinetics and Pharmacodynamics of Doxacurium in Normal Patients and in Those With Hepatic or Renal Failure
&NA; We determined the pharmacokinetics and duration of action of a bolus dose of doxacurium (15 μg/kg) in 27 patients… 
1990
1990
Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function.
The characteristics of neuromuscular block induced by doxacurium were compared in patients with and without renal function… 
1989
1989
Doxacurium chloride: a preliminary clinical trial.
The onset, duration of action and reversibility of doxacurium were studied in 27 anaesthetized patients, using doses of 37.5… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)